Neoadjuvant endocrine therapy for breast cancer: More questions than answers

被引：13

作者：

Ellis, MJ ^{[1
]}

机构：

[1] Washington Univ, Div Oncol, Siteman Comprehens Canc Ctr, St Louis, MO USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 22期

关键词：

D O I：

10.1200/JCO.2005.92.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

收藏

页码：4842 / 4844

页数：3

相关论文

共 7 条

[1]

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study [J].

Eiermann, W ;

Paepke, S ;

Appfelstaedt, J ;

Llombart-Cussac, A ;

Eremin, J ;

Vinholes, J ;

Mauriac, L ;

Ellis, M ;

Lassus, M ;

Chaudri-Ross, HA ;

Dugan, M ;

Borgs, M ;

Semiglazov, V .

ANNALS OF ONCOLOGY, 2001, 12 (11) :1527-1532

[2]

Neoadjuvant endocrine therapy as a drug development strategy [J].

Ellis, MJ .

CLINICAL CANCER RESEARCH, 2004, 10 (01) :391S-395S

[3]

Ellis MJ, 2003, CANCER RES, V63, P6523

[4]

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer:: Evidence from a phase III randomized trial [J].

Ellis, MJ ;

Coop, A ;

Singh, B ;

Mauriac, L ;

Llombert-Cussac, A ;

Jänicke, F ;

Miller, WR ;

Evans, DB ;

Dugan, M ;

Brady, C ;

Quebe-Fehling, E ;

Borgs, M .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) :3808-3816

[5]

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer [J].

Paik, S ;

Shak, S ;

Tang, G ;

Kim, C ;

Baker, J ;

Cronin, M ;

Baehner, FL ;

Walker, MG ;

Watson, D ;

Park, T ;

Hiller, W ;

Fisher, ER ;

Wickerham, DL ;

Bryant, J ;

Wolmark, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2817-2826

[6]

Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial [J].

Smith, IE ;

Dowsett, M ;

Ebbs, SR ;

Dixon, JM ;

Skene, A ;

Blohmer, JU ;

Ashley, SE ;

Francis, S ;

Boeddinghaus, I ;

Walsh, G .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5108-5116

[7]

First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen? [J].

Wong, ZW ;

Ellis, MJ .

BRITISH JOURNAL OF CANCER, 2004, 90 (01) :20-25